VEGFA and vitreous hemorrhage: Despite the use of anti-vascular endothelial growth factor (anti-VEGF) drugs or lasers for the treatment of PDR, vitrectomy is still required in up to one-third of eyes with PDR mainly due to the occurrence of non-clearing vitreous hemorrhage [7,8].